Fig. 9From: A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinomaThe important target genes were mainly distributed in the PI3K-AKT A and EGFR-TKI resistance B and NSCLC C signaling pathwaysBack to article page